HR 6283 118th Congress House Health Civil actions and liability Health care costs and insurance Prescription drugs User charges and fees

DRUG Act

Introduced: February 13, 2024 Introduced by: Miller-Meeks, Mariannette Republican · Iowa See on congress.gov

Everywhere this bill has been 6 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Dec 17, 2024

Referred to the Subcommittee on Health.

Feb 6, 2024

Ordered to be Reported (Amended) by the Yeas and Nays: 29 - 11.

Feb 6, 2024

Committee Consideration and Mark-up Session Held

Nov 10, 2023

Referred to the Subcommittee on Health.

Nov 8, 2023

Introduced in House

Nov 8, 2023

Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Education and the Workforce, and Oversight and Accountability, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

What's happening now December 17, 2024

Referred to the Subcommittee on Health.

Bill text 1 version

Introduced in House Formatted Text PDF Formatted XML

Source documents hosted by congress.gov.

Committees of jurisdiction 6

Education and Workforce Committee
House of Representatives
Energy and Commerce Committee
House of Representatives
Health Subcommittee
House of Representatives · subcommittee of Energy and Commerce Committee
Health Subcommittee
House of Representatives · subcommittee of Ways and Means Committee
Oversight and Government Reform Committee
House of Representatives
Ways and Means Committee
House of Representatives

Lobbying activity 19

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

HEALTHCARE INSTITUTE OF NEW JERSEY
for HEALTHCARE INSTITUTE OF NEW JERSEY · New Jersey · 2nd Quarter (Apr 1 - June 30) 2026
AEGIS LLC
for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · District of Columbia · 2nd Quarter (Apr 1 - June 30) 2026
HEALTHCARE INSTITUTE OF NEW JERSEY
for HEALTHCARE INSTITUTE OF NEW JERSEY · New Jersey · 1st Quarter (Jan 1 - Mar 31) 2026
AEGIS LLC
for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · District of Columbia · 1st Quarter (Jan 1 - Mar 31) 2026
GSK (FKA GLAXOSMITHKLINE INC.)
for GSK (FKA GLAXOSMITHKLINE INC.) · District of Columbia · 4th Quarter (Oct 1 - Dec 31) 2025
HEALTHCARE INSTITUTE OF NEW JERSEY
for HEALTHCARE INSTITUTE OF NEW JERSEY · New Jersey · 4th Quarter (Oct 1 - Dec 31) 2025